CDK4/6 inhibitor is named as a drug or biological intervention in 9 clinical trials in our China trial register, 7 of which are recruiting. Lead sponsors include Fudan University (5), Peking Union Medical College (1) and Wenjin Yin (1). Registered phases: Phase 2, Phase 3 and Observational. Conditions studied include Breast Cancer; Advanced Breast Cancer; Adjuvant Therapy.
Registers list studies that are recruiting, about to open, active but closed to enrolment, or enrolling by invitation. The UK and USA registers cover industry-sponsored studies only. Trial titles and statuses are copied from the registry as published.
| Condition (as registered) | Trials |
|---|---|
| Breast Cancer | 5 |
| Advanced Breast Cancer | 2 |
| Adjuvant Therapy | 1 |
| HR+/HER2- Breast Cancer | 1 |
| Salivary Gland Carcinoma | 1 |
| Precision Therapy | 1 |
| Breast | 1 |
| Lead sponsor | Trials |
|---|---|
| Fudan University | 5 |
| Peking Union Medical College | 1 |
| Wenjin Yin | 1 |
| Cancer Institute and Hospital, Chinese Academy of Medical Sciences | 1 |
| RenJi Hospital | 1 |
| Register | CDK4/6 inhibitor trials |
|---|---|
| Clinical trials in China | 9 |
A trial with sites in more than one country appears in each of those registers.
Everything on this page is copied from public ClinicalTrials.gov registry records — it is not written from memory, and nothing here describes how CDK4/6 inhibitor works or whether it is effective. Each trial links to its own record so you can check it yourself.
This page is built automatically: a daily sync job reads the registry records behind our country trial registers, collects every trial that lists CDK4/6 inhibitor (or a registered synonym) as a drug or biological intervention, and tabulates the registry fields directly. Placebos and generic comparators are excluded. There is no AI drafting and no per-compound editorial pass, and the page has not been clinically reviewed. The “last verified” date above is the timestamp of that sync, not a review date. Our general editorial approach is described in our editorial standards and corrections policy. The ClinicalTrials.gov data on this page was last retrieved on 24 Sep 2026.